Definitive Contract HHSF223201710077C
Award Date 8/10/17
Potential Completion Date 8/31/22
Potential Value $4.5M
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Tallahassee, FL 32399, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Food and Drug Administration awarded a firm fixed price definitive contract valued at one million one hundred thirty thousand fifteen dollars and eighty-one cents ($1,130,015.81) to the Florida Department of Health for MQSA inspections. The place of performance is Tallahassee, Florida. No set-aside designation was used for this contract. As the designated state health agency for Florida, the Department of Health will utilize its resources across the state to conduct Mammography Quality...
- This is a $5,217,515.06 firm-fixed-price definitive contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to the Florida Department of Health (FDOH). The contract has an ultimate completion date of September 25, 2027 and is not a set-aside. FDOH, a state government agency, will provide specialized newborn screening services primarily to the Defense Health Agency, conducting comprehensive testing and case management for military treatment facilities in Florida,...
- This is a firm fixed-price delivery order contract awarded by the Department of the Navy Bureau of Medicine and Surgery to the Florida Department of Health (DOH) for newborn screening services. The $143,653.41 contract has an end date of April 30, 2018. As the designated state health agency, DOH has received various prime and subcontract awards from federal agencies like the Defense Health Agency, Department of Homeland Security, and Department of Health and Human Services to provide public...
- The Department of Health and Human Services Food and Drug Administration awarded a $2,499,744.63 firm fixed price definitive contract to the New York State Department of Health (NYSDOH) for statewide mammography inspections in New York. This contract has no set-aside designation. The NYSDOH, as a U.S. state government entity, provides a range of public health services and has received various federal grants and contracts from agencies such as the Department of Health and Human Services,...
- This is a definitive contract awarded by the Department of Health and Human Services Food and Drug Administration to the Massachusetts Department of Public Health, a U.S. state government entity, for Mass MQSA (Mammography Quality Standards Act) inspections. The contract has a firm fixed price pricing type and a potential value of $1,711,136.29. It was awarded on June 1, 2017 with a completion date of June 30, 2022. This contract is not associated with a larger vehicle and does not have a...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price, definitive contract valued at one hundred thirty-nine thousand, nine hundred thirty dollars and two cents ($139,930.02) to the Hawaii Department of Health for mammography inspection services in Honolulu, Hawaii. As the prime contractor, the Hawaii Department of Health will perform inspections under the contract through its Children With Special Health Needs - Newborn Screening division. The...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $1,248,124.92 firm fixed price definitive contract to the Missouri Department of Health & Senior Services (DHSS) for Missouri Mammography Inspections. The contract, which has no set-aside designation, runs through September 29, 2022. As the state health agency for Missouri, DHSS provides a wide range of public health services and has been awarded over $150 million in federal contracts, including...
- The Food and Drug Administration awarded a firm fixed-price purchase order to the Mississippi State Department of Health (MSDH) Finance & Accounts Division for MQSA (Mammography Quality Standards Act) inspections and general inspections services. The contract, valued at $25,733.27, was awarded on April 28, 2004, with an ultimate completion date of June 27, 2005. Performance of this work occurred in Jackson, Mississippi. No socioeconomic set-aside was utilized for this award. The MSDH, a...
- This is a definitive, firm-fixed-price contract valued at $984,998.12 awarded by the Food and Drug Administration (FDA) to the Department of State Health Services (DSHS), a U.S. state government entity, for MQSA (Mammography Quality Standards Act) inspections. The contract has an ultimate completion date of August 31, 2007 and was awarded on September 1, 2005. This contract does not have a set-aside designation. DSHS is serving as the prime contractor and has an extensive history of executing...
- This is a definitive contract awarded by the Food and Drug Administration (FDA) to the New York State Department of Health (NYSDOH) to provide Medical Quality Assurance (MQSA) inspections in New York State. The contract has a ceiling value of $4,377,586.14 and a period of performance through March 29, 2028. The contract is a firm-fixed-price arrangement with no set-aside designation. NYSDOH, as a U.S. state government entity, has previously received federal contract awards and grants from...